July 17, 2015 : Episode 1

Gefitinib Approved for NSCLC, Atezolizumab Shrinks Bladder Tumors, and More

Video

Related Videos
Wenxin (Vincent) Xu, MD,
Joseph Mikhael, MD
Wenxin (Vincent) Xu, MD
A panel of 4 experts on bladder cancer
A panel of 4 experts on bladder cancer
Ariel F. Grajales-Cruz, MD, Moffitt Cancer Center
Arya Amini, MD
Wenxin (Vincent) Xu, MD
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma